Loxo Oncology
Biotechnology ResearchConnecticut, United States11-50 Employees
Loxo Oncology develops oncological drugs for well-defined patient groups, whose cancers share common genetic drivers.
Insights
Strategic Partnerships Loxo Oncology has been actively forming strategic partnerships with companies like Foghorn Therapeutics, Kumquatbiosciences, and Merus B.V. These collaborations not only enhance the company's research capabilities but also open doors for potential sales opportunities through joint ventures and product development.
Key Personnel Promotion The recent promotion of Jacob Van Naarden to senior vice president and CEO at Loxo Oncology indicates a shift in leadership towards driving growth and innovation. Leveraging this change in leadership, sales development representatives can explore new channels and decision-makers within the organization for partnership discussions and potential sales.
Investments in Innovation The significant investments made by Loxo Oncology into companies like Merus B.V. demonstrate a commitment to advancing innovative therapies. Sales development professionals can leverage these investments as entry points to pitch complementary products or services that align with Loxo's research and development focus.
Market Expansion With Loxo Oncology's focus on developing oncological drugs for specific patient groups, there is an opportunity to align sales strategies with the company's expansion plans into new geographical markets or therapeutic areas. Understanding these expansion goals can help sales professionals tailor their pitches effectively.
Public Offering Having gone public in 2014, Loxo Oncology has a history of financial transactions that could indicate potential future fundraising or investment activities. Sales development representatives can leverage this information to engage in discussions around potential partnership opportunities that align with the company's growth trajectory.
Similar companies to Loxo Oncology
Schrödinger
966
$100M$1BPrelude Therapeutics
149$10M$50MDeciphera Pharmaceuticals
413$50M$100MChemoCentryx
60$10M$50MSpringWorks Therapeutics
327$50M$100MRepare Therapeutics
192$10M$50MHarpoon Therapeutics
54$10M$50MNimbus Therapeutics
106$10M$50MRevolution Medicines
459$50M$100MFogPharma
145$10M$50M
Loxo Oncology Tech Stack
Loxo Oncology uses 8 technology products and services including Oracle, Typekit, Microsoft, and more. Explore Loxo Oncology's tech stack below.
- OracleEnterprise
- TypekitFont Scripts
- MicrosoftMiscellaneous
- PWAMiscellaneous
- Open GraphMiscellaneous
- X-XSS-ProtectionSecurity
- Google Tag ManagerTag Management
- FedExTransportation And Fleet Management
Media & News
Loxo Oncology's Email Address Formats
Loxo Oncology uses at least 1 format(s):
| Loxo Oncology Email Formats | Percentage |
| FLast@loxooncology.com | 91% |
| First.Last@loxooncology.com | 4% |
| First@loxooncology.com | 4% |
| Last@loxooncology.com | 1% |
Frequently Asked Questions
Where is Loxo Oncology's headquarters located?
Loxo Oncology's main headquarters is located at One Landmark SquareSuite 1120 Stamford, CT 06901 United States. The company has employees across 2 continents, including North AmericaAsia. What is Loxo Oncology's stock symbol?
Loxo Oncology is a publicly traded company; the company's stock symbol is LOXO. What is Loxo Oncology's official website and social media links?
Loxo Oncology's official website is loxooncology.com and has social profiles on LinkedIn.What is Loxo Oncology's SIC code NAICS code?
Loxo Oncology's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).How many employees does Loxo Oncology have currently?
As of October 2024, Loxo Oncology has approximately 11 employees across 2 continents, including North AmericaAsia. Key team members include Associate Vice President, Business Development & Discovery: H. F.Senior Vice President Small Molecule Discovery: S. A.Senior Director, Clinical Biomarkers And Diagnostic Development: A. U.. Explore Loxo Oncology's employee directory with LeadIQ.What industry does Loxo Oncology belong to?
Loxo Oncology operates in the Biotechnology Research industry. What technology does Loxo Oncology use?
Loxo Oncology's tech stack includes OracleTypekitMicrosoftPWAOpen GraphX-XSS-ProtectionGoogle Tag ManagerFedEx. What is Loxo Oncology's email format?
Loxo Oncology's email format typically follows the pattern of . Find more Loxo Oncology email formats with LeadIQ. 
Company Overview
- Headquarters
- One Landmark SquareSuite 1120 Stamford, CT 06901 United States
- Website
- loxooncology.com
- SIC Code
- 8733 - Noncommercial Research Organizations
- Stock Symbol
- LOXO
- NAICS Code
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
- Employees
- 11-50
Media & News
Funding & Financials
Funding & Financials
Company Leadership
H. F.Associate Vice President, Business Development & Discovery
S. A.Senior Vice President Small Molecule Discovery- A. U.Senior Director, Clinical Biomarkers And Diagnostic Development
- D. H.Executive Director
D. W.Associate Director, Analytical Chemistry, Cmc
Employee Directory
- G. S.Associate Director
- H. L.Associate Director
- J. K.Senior Medical Director
- K. F.Director, Clinical Development
- M. A.Director Of Transformation
1-888-653-2347 
support@leadiq.com © LeadIQ, Inc. All rights reserved.
